- Home
- BMRA vs SLXN Comparison
BMRA vs SLXN Comparison
Compare BMRA & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRA
- SLXN
- Stock Information
- Founded
- BMRA 1971
- SLXN 2008
- Country
- BMRA United States
- SLXN Israel
- Employees
- BMRA N/A
- SLXN N/A
- Industry
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- SLXN
- Sector
- BMRA Health Care
- SLXN
- Exchange
- BMRA Nasdaq
- SLXN NYSE
- Market Cap
- BMRA 5.9M
- SLXN 5.2M
- IPO Year
- BMRA N/A
- SLXN N/A
- Fundamental
- Price
- BMRA $0.64
- SLXN $0.88
- Analyst Decision
- BMRA
- SLXN Strong Buy
- Analyst Count
- BMRA 0
- SLXN 1
- Target Price
- BMRA N/A
- SLXN $9.00
- AVG Volume (30 Days)
- BMRA 20.4M
- SLXN 1.6M
- Earning Date
- BMRA 01-14-2025
- SLXN 02-21-2025
- Dividend Yield
- BMRA N/A
- SLXN N/A
- EPS Growth
- BMRA N/A
- SLXN N/A
- EPS
- BMRA N/A
- SLXN N/A
- Revenue
- BMRA $5,578,000.00
- SLXN N/A
- Revenue This Year
- BMRA N/A
- SLXN N/A
- Revenue Next Year
- BMRA N/A
- SLXN N/A
- P/E Ratio
- BMRA N/A
- SLXN N/A
- Revenue Growth
- BMRA 1.40
- SLXN N/A
- 52 Week Low
- BMRA $0.24
- SLXN $0.21
- 52 Week High
- BMRA $1.35
- SLXN $13.56
- Technical
- Relative Strength Index (RSI)
- BMRA 73.05
- SLXN N/A
- Support Level
- BMRA $0.29
- SLXN N/A
- Resistance Level
- BMRA $1.27
- SLXN N/A
- Average True Range (ATR)
- BMRA 0.09
- SLXN 0.00
- MACD
- BMRA 0.04
- SLXN 0.00
- Stochastic Oscillator
- BMRA 36.36
- SLXN 0.00
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.
About SLXN BIOMOTION SCIENCES
Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.